Hussein Abkallo

Hussein Abkallo

Hussein Abkallo joined ILRI in August 2017 as a Post-Doctoral Fellow (Molecular Biology & Virology) with a remit to establish the cutting edge CRISPR/Cas9 technology for editing ASF virus genome, as well as the development of a reverse genetics system for generating synthetic ASF viral genomes, with a view to developing live attenuated vaccines (LAVs) against ASF virus. Hussein is a Biomedical Scientist who holds a PhD & MSc in Medical Sciences (Infections Research) from the Institute of Tropical Medicine, Nagasaki University, Japan and BSc Biomedical Sciences from Maseno University, Kenya. Before joining ILRI, he was a Royal Society Newton International Fellow at the University of Edinburgh in the UK where he was using CRISPR/Cas9 to edit P. falciparum genome. Hussein is keen on broader applications of CRISPR/Cas technology and Synthetic biology in developing vaccines and establishing ultra-sensitive diagnostics.